Recent director dealings and insider transactions at UnitedHealth Group Incorporated (UNH),
from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
Date
Insider
Type
Shares
2026-10-01
Mcnabb Frederick William Iii
BUY
291
2026-10-01
Gil Kristen
BUY
240
2026-10-01
Montgomery Rice Valerie Md
BUY
257
2026-10-01
Noseworthy John H
BUY
240
2026-10-01
Baker Charles D.
BUY
257
2026-10-01
Flynn Timothy Patrick
BUY
262
2026-10-01
Gottlieb Scott
BUY
257
2026-10-01
Garcia Paul R
BUY
103
2026-10-01
Garcia Paul R
BUY
155
2026-09-22
Stankiewicz Dennis Andrew
BUY
51
Valuation
P/E RatioN/A
Market Cap$368.36B
Beta0.615
Dividend/yrNone
52W High$461.62
52W Low$255.97
52-Week Range
$255.97Now$461.62
75% through annual range
From 52W High−11.1%
From 52W Low+60.3%
📖 Plain English Summary
UnitedHealth Group Incorporated is at 75% of its 52-week range. Beta 0.615 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for UNH🟢 Bullish⬜ Neutral🔴 Bearish
🤖
DipBuster AI Analysis — UNH
Heuristic · balance sheet, insider filings, price data, academic research
UnitedHealth Group Incorporated — DipBuster Score 23/100
Graham value assessment, NCAV analysis, price zones...
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, a…